P.136 Design of Reach: Phase 3 Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of the Efficacy and Safety of Losmapimod in FSHDAlrabi Tawil,Jay Han,Leo Wang,John Vissing,Jeffrey Statland,Jennifer Shoskes,John JiangNEUROLOGY（2023）引用 1|浏览41关键词Molecular PharmingAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
